Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Trial of Inhaled Sevoflurane Sedation in ICU Patients at Risk of ARDS
2020-001813-18Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of sevoflurane in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Longitudinal evolution in PaO2/FiO2 ratio. Started Jun 2020; status: active.
02
Drugs
sevoflurane
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2020-001813-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001813-18.